What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Jennifer R. Brown mostly deals with Internal medicine, Chronic lymphocytic leukemia, Cancer research, Immunology and Oncology.
As a member of one scientific family, Jennifer R. Brown mostly works in the field of Internal medicine, focusing on Surgery and, on occasion, Incidence.
Her Chronic lymphocytic leukemia study introduces a deeper knowledge of Leukemia.
The study incorporates disciplines such as Mutation, RNA splicing, Spliceosome, Cell cycle and Kinase in addition to Cancer research.
Her Immunology study incorporates themes from Cancer and Neutropenia.
She interconnects Survival rate, Lymphoma, Transplantation and Chemoimmunotherapy in the investigation of issues within Oncology.
Her most cited work include:
- Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. (991 citations)
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia (979 citations)
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia (979 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Chronic lymphocytic leukemia, Internal medicine, Oncology, Cancer research and Immunology.
The subject of her Chronic lymphocytic leukemia research is within the realm of Leukemia.
Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Surgery.
Her Oncology research includes elements of IGHV@, Bendamustine, Transplantation and Chemoimmunotherapy.
Her Cancer research research integrates issues from Mutation, Apoptosis, B cell, breakpoint cluster region and Kinase.
Her work deals with themes such as Adverse effect, Clinical trial and Bruton's tyrosine kinase, which intersect with Ibrutinib.
She most often published in these fields:
- Chronic lymphocytic leukemia (56.07%)
- Internal medicine (49.77%)
- Oncology (30.41%)
What were the highlights of her more recent work (between 2018-2021)?
- Chronic lymphocytic leukemia (56.07%)
- Internal medicine (49.77%)
- Oncology (30.41%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Chronic lymphocytic leukemia, Internal medicine, Oncology, Ibrutinib and Cancer research.
Her research in Chronic lymphocytic leukemia intersects with topics in Cancer and Clinical trial.
Her work on Neutropenia, Adverse effect and Fludarabine as part of general Internal medicine research is often related to In patient, thus linking different fields of science.
Her work in Oncology addresses subjects such as Obinutuzumab, which are connected to disciplines such as Untreated Chronic Lymphocytic Leukemia.
Her work in Ibrutinib addresses issues such as Bruton's tyrosine kinase, which are connected to fields such as B cell.
The various areas that Jennifer R. Brown examines in her Cancer research study include Idelalisib, T cell, Stem cell, Lymphoma and Epigenetics.
Between 2018 and 2021, her most popular works were:
- Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab. (76 citations)
- Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma (64 citations)
- Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib (63 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Her primary areas of investigation include Ibrutinib, Chronic lymphocytic leukemia, Internal medicine, Cancer research and Leukemia.
Her studies in Ibrutinib integrate themes in fields like Progression-free survival, Bruton's tyrosine kinase, Confidence interval and IGHV@.
Her Chronic lymphocytic leukemia research is multidisciplinary, incorporating perspectives in Pandemic and Severe acute respiratory syndrome coronavirus 2.
Internal medicine is closely attributed to Oncology in her study.
The Cancer research study combines topics in areas such as Waldenstrom macroglobulinemia, Lymphoma and microRNA.
Her studies deal with areas such as Cancer, Hematology, Disease and Phosphatidylinositol, Kinase as well as Leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
